Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer therapy. Shows potential in medicinal chemistry due to its ability to enhance metabolic stability and binding affinity in drug candidates. Also employed in research settings to explore structure-activity relationships in nicotinamide-based analogs. Its cyclopropyl group contributes to improved pharmacokinetic properties, making it valuable in optimizing lead compounds for central nervous system disorders.